Kymera Therapeutics, Inc. Share Price

Kymera Therapeutics, Inc. Share Price

NASDAQ: KYMR | Large Cap
$122.65
+$0.03 (0.02%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Kymera Therapeutics, Inc. Stock Performance

Open
$125.01
Prev. Close
$122.62
Circuit Range
N/A
Day Range
$118.42 - $127.35
Year Range
$56.75 - $129.83
Volume
75,741
Average Traded
$122.00

Kymera Therapeutics, Inc. Share Price Today

As of 30 October 2026, Kymera Therapeutics, Inc.'s share price is $122.65. The stock opened at $125.01, compared to its previous close of $122.62. During today's trading session, Kymera Therapeutics, Inc.'s share price traded between $118.42 and $127.35, with an average price of $122.88. Over the past 52 weeks, the stock has recorded a high of $129.83 and a low of $56.75. In terms of performance, Kymera Therapeutics, Inc.'s share price has risen by 51.29% over the last six months and is up 98.24% on a year-on-year basis.

Kymera Therapeutics, Inc. Share Price Chart

Line chart of the Kymera Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 117.90 to 127.59, ending at 122.65.
$118.42$127.35
L
Show Current Price
H

Kymera Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$10.36B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.60
Revenue (TTM)
$39.21B
Return On Equity (TTM)
-19.85%
Profit Margin
-794.06%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
25.52%

Kymera Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.76$2.87$34.37$65.00
Net Profit-$82.18-$86.98-$69.23-$61.21
Net Profit Margin-2977.54%-3030.66%-201.43%-94.17%
Income ChangeN/A-5.84%20.41%11.58%

Kymera Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$46.83$78.59$47.07$39.21
Net Profit-$154.81-$146.96-$223.86-$311.35
Net Profit Margin-330.58%-187.00%-475.59%-794.06%
Income ChangeN/A5.07%-52.33%-39.08%

About Kymera Therapeutics, Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

Kymera Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$111.47
$122.70
+9.41%
Sep 2026
$117.02
$112.15
-6.64%
Aug 2026
$100.86
$120.13
+16.28%
Jul 2026
$114.11
$103.31
-9.96%
Jun 2026
$80.66
$114.74
+40.88%
May 2026
$80.78
$81.44
+0.46%
Apr 2026
$84.45
$81.07
-2.68%
Mar 2026
$90.05
$83.31
-8.84%
Feb 2026
$71.60
$91.38
+25.71%
Jan 2026
$77.83
$72.69
-6.48%
Dec 2025
$66.75
$77.73
+14.49%
Nov 2025
$62.99
$67.89
+9.73%

KYMR Share Price FAQs